Life science research and clinical diagnostic products manufacturer Bio-Rad Laboratories has acquired AbD Serotec, a division of MorphoSys. Under the transaction, Bio-Rad paid euro 53m in cash to AbD Serotec, which offers over 15,000 ...
Tags: clinical diagnostic products, Bio-Rad Laboratories, AbD Serotec
Germany based MorphoSys has closed the transaction of selling its AbD Serotec segment to Bio-Rad. Transfer of all assets and liabilities of MorphoSys'research and diagnostic antibody segment,the AbD Serotec,in addition to all shares of ...
Tags: shares, AbD Serotec, Bio-Rad, divestment
Clinical diagnostic tools manufacturer Bio-Rad Laboratories has agreed to buy AbD Serotec for €53m ($69.7m) in cash. The transaction, signed under the definitive agreement, is subject to certain closing conditions and is expected to ...
Tags: Clinical diagnostic tools, diagnostic tools, antibody, Bio-Rad
Bio-Rad Laboratories has entered into an agreement to purchase a division of MorphoSys, AbD Serotec, for euro 53m. The deal, which is anticipated to complete in January 2013, is subject to certain closing conditions. Bio-Rad life ...
Tags: Bio Rad, Abd Serotec, antibodies, cell sorting
AbD Serotec, MorphoSys' division for research and diagnostic antibodies, is set to introduce a series of the human combinatorial antibody library (HuCAL) anti-drug antibodies supporting the development of novel antibody therapeutics. The ...
Tags: AbD Serotec, HuCAL Anti-Drug Antibodies, antibody therapeutics, MorphoSys